| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/05/2007 | WO2007037430A1 T-cell adhesion molecule and antibody directed against the molecule |
| 04/05/2007 | WO2007037299A1 Substance inhibiting the expression of hb24 or the transcriptional regulatory activity thereof, use of the same and method of screening the substance |
| 04/05/2007 | WO2007037273A1 Introduction of substance into cell by using nanoparticle having cell membrane-permeable peptide displayed thereon |
| 04/05/2007 | WO2007037265A1 Dna vaccine composition |
| 04/05/2007 | WO2007036735A2 Immunogenic agents againts burkholderia psudomallei and/or burkholderia mallei, comprising lipopolysaccharide, capsular polysaccharide and/or proteins from burkholderia psuedomallei |
| 04/05/2007 | WO2007036638A1 Cd4+ t survivin epitopes and uses thereof |
| 04/05/2007 | WO2007036041A1 Sialidase inhibitors for the treatment of cardiovascular disease |
| 04/05/2007 | WO2007036036A1 Method and composition for increasing the engraftment efficiency of stem cells |
| 04/05/2007 | WO2007017154A3 Human inhibitory anti-factor viii antibodies binding to the a2 domain |
| 04/05/2007 | WO2007013945A3 Treating disorders associated with inflammation |
| 04/05/2007 | WO2007011210A3 Parechovirus, vaccines, medicaments and diagnostic kits |
| 04/05/2007 | WO2007006939A3 Thermoreversible immuno-adjuvant emulsion |
| 04/05/2007 | WO2007006712A3 Mycoplasma subunit vaccine |
| 04/05/2007 | WO2007005358A3 Method for preparing a covalently cross linked oligomer of amyloid beta peptides |
| 04/05/2007 | WO2006138708B1 Lkktet and/or lkktnt peptide compositions which are lyophilized or in a form capable of being lyophilized |
| 04/05/2007 | WO2006133286A3 Treatment of tnf antagonist-resistant inflammatory disorders and related methods |
| 04/05/2007 | WO2006119983A3 Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy |
| 04/05/2007 | WO2006119527A3 Melanoma-associated endogenous retrovirus (merv) derived peptide sequences and their therapeutic/ diagnostic use |
| 04/05/2007 | WO2006114312A3 Vaccine |
| 04/05/2007 | WO2006113927A3 Immunogenic vaccinia peptides and methods of using same |
| 04/05/2007 | WO2006112930A3 Q3 sparc deletion mutant and uses thereof |
| 04/05/2007 | WO2006110594A3 Sema4d in cancer diagnosis, detection and treatment |
| 04/05/2007 | WO2006109195A3 Modulation of an immune response by filamentous haemagglutinin |
| 04/05/2007 | WO2006102099A3 ANTIBODIES SPECIFIC FOR HUMAN AND BOVINE PrP |
| 04/05/2007 | WO2006096626A3 Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| 04/05/2007 | WO2006095176A3 Vaccine formulation |
| 04/05/2007 | WO2006094384B1 Use of interleukin 17e for the treatment of cancer |
| 04/05/2007 | WO2006093824A3 Influenza virus harvester |
| 04/05/2007 | WO2006091728A3 Microtubule stabilizing compounds and methods of their use |
| 04/05/2007 | WO2006089264A3 Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli |
| 04/05/2007 | WO2006089043A3 Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis |
| 04/05/2007 | WO2006074418A3 Ovr110 antibody compositions and methods of use |
| 04/05/2007 | WO2006071877A3 Orally deliverable and anti-toxin antibodies and methods for making and using them |
| 04/05/2007 | WO2006029300A8 Flavivirus variants having phenotypic variation and immunogenic compositions thereof |
| 04/05/2007 | WO2006026820A9 Treating gliosis, glial scarring, inflammation or inhibition of axonal growth in the nervous system by modulating eph receptor |
| 04/05/2007 | WO2005094159A3 Methods of identifying neoplasm-specific antibodies and uses thereof |
| 04/05/2007 | WO2003070751A3 Partial peptide mimetics and methods |
| 04/05/2007 | US20070078260 Chemokine panec-2 polynucleotides, polypeptides, antibodies and methods of making and using them |
| 04/05/2007 | US20070078104 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; antiinflammatory agents |
| 04/05/2007 | US20070078101 Regulation of tgf-beta signaling by tomoregulin |
| 04/05/2007 | US20070077627 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 04/05/2007 | US20070077624 Recombinant production of mixtures of antibodies |
| 04/05/2007 | US20070077585 interleukins (IL-13); RNA expression; emphysema, asthma and chronic obstructive pulmonary disorder |
| 04/05/2007 | US20070077559 Newcastle disease virus administration |
| 04/05/2007 | US20070077272 Solid polymer delivery compositions and methods for use thereof |
| 04/05/2007 | US20070077260 Vaccines for mycoplasma bovis and methods of use |
| 04/05/2007 | US20070077259 Polylysine positively charged backbone, oligoarginine branching group, hydroxypropylcellulose viscosity modifying agent; treat wrinkles, hyperhidrosis, neurologic pain, migraine headache, reducing muscle spasms, preventing or reducing acne; reduced training necessary for applying botulinum therapeutic |
| 04/05/2007 | US20070077258 ADMINISTRATION OF GLUTATHIONE (REDUCED) VIA INTRAVENOUS OR ENCAPSULATED IN LIPOSOME FOR THE AMELIORATION OF TNF-alpha EFFECTS AND FLU-LIKE VIRAL SYMPTOMS AND TREATMENT AND PREVENTION OF VIRUS |
| 04/05/2007 | US20070077257 Enhanced first generation adenovirus vaccines expressing condon optimized HIV1-Gag, Pol, Nef and modifications |
| 04/05/2007 | US20070077256 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| 04/05/2007 | US20070077255 Isolation and characterization of a cDNA clone encoding one IgE-binding fragment of Penicillium brevicompactum |
| 04/05/2007 | US20070077254 Targeting the histone code as a bacterial strategy for selectively modulating gene expression |
| 04/05/2007 | US20070077253 Multilayer thin film comprising two or more adjacent layers of oppositely charged polyelectrolytes and encapsulated antigenic peptides; vaccine development |
| 04/05/2007 | US20070077252 Laminin chains: diagnostic uses |
| 04/05/2007 | US20070077251 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 04/05/2007 | US20070077250 Novel core 2 beta-1,6-N-acetylglycosaminyltransferase gene |
| 04/05/2007 | US20070077249 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 04/05/2007 | US20070077248 Tumour necrosis factor binding ligands |
| 04/05/2007 | US20070077247 Receptor on the surface of activated T-cells: ACT-4 |
| 04/05/2007 | US20070077246 Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity |
| 04/05/2007 | US20070077245 NOTCH mutations leading to increased receptor signaling |
| 04/05/2007 | US20070077244 Inhibitor protein of the wnt signal pathway |
| 04/05/2007 | US20070077243 Method for making humanized antibodies |
| 04/05/2007 | US20070077242 Tumor necrosis factor specific immunoglobulin for use in treatment and prevention of tumor disorder; tissue targeted therapy |
| 04/05/2007 | US20070077241 Activation of Lymphocyte Populations Expressing NKG2D Using Anti-NKG2D Antibodies and Ligand Derivatives |
| 04/05/2007 | US20070077240 having determined antigen specificity, and having a variable fragment which is obtainable from a camelid heavy-chain immunoglobulin having two heavy polypeptide chains capable of recognizing and binding an antigen and which is further devoid of polypeptide light chains |
| 04/05/2007 | US20070077234 Regulation of T cell-mediated immunity by tryptophan |
| 04/05/2007 | US20070077229 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin |
| 04/05/2007 | US20070077224 Regulation of T cell-mediated immunity by tryptophan |
| 04/05/2007 | US20070077199 Humanized collagen antibodies and related methods |
| 04/05/2007 | CA2624498A1 Cd4+ t survivin epitopes and uses thereof |
| 04/05/2007 | CA2624138A1 Method and composition for increasing the engraftment efficiency of stem cells |
| 04/05/2007 | CA2624135A1 T-cell adhesion molecule and antibody thereto |
| 04/05/2007 | CA2623517A1 Antibodies with simultaneous subsite specificities to protein and lipid epitopes |
| 04/05/2007 | CA2623429A1 Interleukin-13 antibody composition |
| 04/05/2007 | CA2623400A1 Immunogenic capsule composition for use as a vaccine component against campylobacter jejuni |
| 04/05/2007 | CA2623387A1 Use of ephrinb2 directed agents for the treatment or prevention of viral infections |
| 04/05/2007 | CA2623236A1 Human monoclonal antibodies to cd70 |
| 04/05/2007 | CA2621623A1 Il-17a and il-17f antagonists and methods of using the same |
| 04/05/2007 | CA2618068A1 Stable aqueous protein or antibody pharmaceutical formulations and their preparation |
| 04/05/2007 | CA2590401A1 Adoptive immunotherapy with enhanced t lymphocyte survival |
| 04/04/2007 | WO2007041637A2 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 04/04/2007 | EP1770168A2 Compositions and methods for delivery of genetic material |
| 04/04/2007 | EP1770164A2 Streptococcus pneumoniae antigens and vaccines |
| 04/04/2007 | EP1770163A2 Antagonists of interleukin-15 |
| 04/04/2007 | EP1770162A1 Immunological compositions to modulate myostatin in vertebrate subjects |
| 04/04/2007 | EP1770101A1 Antibodies against caspase-8, their preparation and use |
| 04/04/2007 | EP1770100A2 Transferrin receptor genes of Moraxella |
| 04/04/2007 | EP1769807A1 Graft rejection suppressors |
| 04/04/2007 | EP1769806A2 Vaccine against HPV |
| 04/04/2007 | EP1769245A2 Identification and engineering of antibodies with variant fc regions and methods of using the same |
| 04/04/2007 | EP1769066A2 Modified antigen-presenting cells |
| 04/04/2007 | EP1769065A1 Vaccine composition against rhodococcus equi |
| 04/04/2007 | EP1769005A2 Measuring degree of polymerisation for capsular saccharides that contain sialic acid |
| 04/04/2007 | EP1769003A1 HIGH AFFINITY ANTI-TNF-alpha ANTIBODIES AND METHOD |
| 04/04/2007 | EP1768995A1 Preparation of protective antigen from bacillus anthracis |
| 04/04/2007 | EP1768703A1 mRNA MIXTURE FOR VACCINATING AGAINST TUMORAL DISEASES |
| 04/04/2007 | EP1768699A1 Induction of apoptosis in toll-like receptor expressing tumor cells |
| 04/04/2007 | EP1768697A2 Recombinant rabies virus compositions |
| 04/04/2007 | EP1768696A2 Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus |